Group B2—Probable Human Carcinogens

Daminozide (Alar) Di(2-ethylhexyl)phthalate Dibromochloropropane (DBCP) Dibromoethane, 1,2-Dichloroethane, 1,2-Dichloromethane Dichloropropene 

Orthophenylphenol and Na salt Oxythioquinox (Morestan) Pentachlorophenol Polychlorinated biphenyls Procymidone (Sumilex) Pronamide (Kerb) 

Toxaphene (Campechlor) Trichlorophenol, 2,4,6-Triphenyltin hydroxide UDMH 

Source U.S. Environmental Protection Agency. 2007. Pesticides Health and Safety Evaluation of Pesticides for Carcinogenic Potential. Washington, D.C. U.S. EPA. 

Difenzoquat methyl sulfate Diflubenzuron Dinocap (Karathane) Diquat dibromide Disulfoton (Disyston) Dithiopyr Esfenvalerate Ethion 

---

Group 2B Possible human carcinogen Group B2 Probable human carcinogen... 

Group B2 - Probable human carcinogen, based on sufficient evidence from animal studies. 

Toxaphene (approximate overall empirical formula of C10Hi0C15) is a persistent, broad-spectrum insecticide with some occurrence in drinking water. Its registered uses are currently limited. The EPA reported that toxaphene is highly persistent and accumulates in the environment. Acute exposure to toxaphene affects various organs in humans. Toxaphene has been classified in the EPA s Group B2 (probable human carcinogen). 

Human health effects from longer-term human exposures to carbon tetrachloride generally resemble acute effects of liver and kidney damage. Consumption of alcohol and poorly controlled diabetes may increase the risk of harmful effects associated with carbon tetrachloride intoxication. The US EPA classifies carbon tetrachloride as a group B2, probable human carcinogen. 

US Environmental Protection Agency (EPA) Group B2 (probable human carcinogen). 

A carcinogenic potential of some chlordimeform metabolites has been demonstrated. The US EPA s Office of Pesticide Programs has classified chlordimeform as a Group B2 - Probable human carcinogen based on findings of malignant hemangioendothelioma in mice. 

Due to a Federal court decision, not enforceable as of March 22, 1993 (Hanson 1993). Group B2 Probable human carcinogen... 

Group B1 Probable Human Carcinogen with Human Data Group B2 Probable Human Carcinogen without Human Data Group C Possible Human Carcinogen... 

HUMAN HEALTH RISKS Inhalation-human TCLo 134 ppm/30M EPA cancer risk level 5E mg/m EPA Group B2 probable human carcinogen Acute Risks irritation of skin, eyes and upper respiratory tract respiratory paralysis erythema coughing pulmonaiy edema necrosis. Chronic Risks effects on liver, kidneys, lungs, blood and CNS symptoms of chronic exposure resemble those of alcoholism. 

HUMAN HEALTH RISKS EPA RfD 0.0002 mg/kg/d EPA cancer risk level 8E-7 mg/m EPA Group B2 probable human carcinogen Acute Risks eye and skin irritation possible nervous system disturbances drowsiness incoordination hallucinations confusion peripheral neuropathy Chronic Risks carcinogen nerve damage damage to cardiovascular system reddish rash adverse blood affects. 

HUMAN HEALTH RISKS EPA group B2 probable human carcinogen Acute Risks gastrointestinal distress skin and eye irritation liver and kidney effects adverse effects on weight gain and appetite Chronic Risks dermatitis. 

HUMAN HEALTH RISKS Inhalation human TCLo 45 ppm/3D EPA cancer risk level 7E-5 mg/m EPA group B2 probable human carcinogen Acute Risks headaches, weakness, lethargy, nausea, delayed pulmonary edema, stomach pains, dermatitis, eye irritation Chronic Risks liver and kidney damage pupillary constriction, coma, tremors, gastrointestinal effects, anorexia, neurological effects. 

HUMAN HEALTH RISKS EPA group B2 probable human carcinogen Acute Risks inflammation and necrosis of the eyes, mouth and respiratory tract ulceration delirium coma severe blistering conjunctivitis catarrhal inflammation of the mucous membranes, nose, throat, larynx and trachea Chronic Risks damage to the lungs, liver, kidneys, heart and CNS prostration suppression of urine pulmonary edema jaundice hematuria albuminuria. 

HUMAN HEALTH RISKS EPA Group B2 probable human carcinogen Acute Risks itching swelling blistering temporary blindness eye and skin burns dermatitis pulmonary edema dizziness nausea seizures Chronic Risks damage to liver and lungs, CNS coma may cause cancer. 

HUMAN HEALTH RISKS EPA Risk Level nonthreshold category EPA Group B2 probable human carcinogen Acute Risks destructive to skin, eyes, mucous membranes and respiratory tract burning sensation diarrhea ataxia cyanosis shortness of breath convulsions liver and kidney damage Chronic Risks impaired function of kidney and, liver effects on blood and spleen. 

---